Financials
Financial year 2025
RX TECH from Herve, company number BE0696610349, closed financial year 2025 with a result of € 1.8 million after tax. For that financial year RX TECH recorded a gross margin of € 168,807 and equity of € 2 million. Compared with financial year 2024, the result moved from € 1.6 million to € 1.8 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 2 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.8 million
▲ 9% vs 2024
Profit after tax over the fiscal year.
€ 493,192
▲ € 476,612 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.8 million paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 1,269
▼ 98% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,851
▼ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 55,898
▼ 88% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,154,903 | € 1,860,306 | € 2,038,222 | € 168,807 | ▼ 92% |
| Profit after taxes | € 781,414 | € 1,972,908 | € 1,637,286 | € 1,779,441 | ▲ 9% |
| Equity | € 2,546,546 | € 2,619,454 | € 1,994,274 | € 1,994,274 | |
| Total debts | € 184,049 | € 1,927,129 | € 2,731,105 | € 2,231,477 | ▼ 18% |
| Cash | € 619,314 | € 827,534 | € 16,580 | € 493,192 | ▲ € 476,612 |
| Retained profit | € 2,513,546 | € 2,586,454 | € 1,961,274 | € 1,961,274 | |
| Dividend | € 0 | € 1,900,000 | € 2,262,466 | € 1,779,441 | ▼ 21% |
| Bank debt | € 20,416 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 2,730,595 | € 4,546,583 | € 4,725,379 | € 4,225,751 | ▼ 11% |
Key figures of RX TECH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RX TECH?
What happened at RX TECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.8 million (▲ 9% vs 2024). Source: NBB ↗
- New establishment in Herve. KBO
- Start of the company according to the CBE. KBO
- EMMANUEL XHAUFLAIR became a director. NBB
- HERVE XHAUFLAIR became a director. NBB
- FRANCOIS RANDAXHE became a director. NBB
In short
From € 781,414 profit in 2022 to € 1.8 million profit in 2025.
Paid € 1.4 million in corporate taxes since 2022.
Best year ever: 2023, with € 2 million profit.
Paid out € 5.9 million in dividends to the owners in total.
Management
Behind RX TECH are EMMANUEL XHAUFLAIR, HERVE XHAUFLAIR and FRANCOIS RANDAXHE. It owns 75% of Applicair itself.
Establishments
Establishment units
Physical locations of this company
Rue de Maestricht 48
4651 Herve
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0696.610.349
- VAT number
- BE 0696.610.349
- Registered office
- Rue de Maestricht 48, 4651 Herve
- Names & denominations
- RX TECH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 May 2018
- Peppol
- Active · Active since 17 Oct 2025
- Activities · NACE
Activiteiten van holdings
Holdings